Supplementary Figure and Table Legends from A Phase I Clinical Trial of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Patients with Recurrent Gynecologic Cancer

MLA

Ronald D. Alvarez, et al. Supplementary Figure and Table Legends from A Phase I Clinical Trial of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Patients with Recurrent Gynecologic Cancer. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a6885887cd3ad13f74e38ed8dcadc41&authtype=sso&custid=ns315887.

APA

Ronald D. Alvarez, David T. Curiel, Kurt R. Zinn, Gene P. Siegal, Rosemarie Aurigemma, Raymond D. Harris, Meredith A. Preuss, Zhiying You, Souheil Saddekni, Minghui Wang, Janis P. O’Malley, Igor Dmitriev, & Kenneth H. Kim. (2023). Supplementary Figure and Table Legends from A Phase I Clinical Trial of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Patients with Recurrent Gynecologic Cancer.

Chicago

Ronald D. Alvarez, David T. Curiel, Kurt R. Zinn, Gene P. Siegal, Rosemarie Aurigemma, Raymond D. Harris, Meredith A. Preuss, et al. 2023. “Supplementary Figure and Table Legends from A Phase I Clinical Trial of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Patients with Recurrent Gynecologic Cancer,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a6885887cd3ad13f74e38ed8dcadc41&authtype=sso&custid=ns315887.